Oral Question·Department of Health and Social Care
“What discussions he has had with King's College London on the compliance of the PATHWAYS puberty blocker trial with the Medicines for Human Use (Clinical Trials) Regulations 2004.”
Tabled: 7 January 2026Answered: 13 January 2026
Asked by
Rosie Duffield
Independent — Canterbury
Answering Minister
the Secretary of State for Health and Social Care
Answer from Hansard
The Minister for Secondary Care (Karin Smyth)
The PATHWAYS trial has undergone a thorough independent review and has received all the regulatory and ethical approvals. The sponsors of the study, King’s College London and South London and Maudsley NHS foundation trust, are working to ensure that it is conducted in compliance with the relevant regulations.